Abbott Labs (ABT) Results Show Investors 5 Reasons To Buy - Raymond James
Tweet Send to a Friend
Raymond James analyst Jayson Bedford reiterated an Outperform rating and $79.00 price target on Abbott Labs (NYSE: ABT) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
